PMA device
Trivisc
Channel-Markers Medical, LLC · Acid, Hyaluronic, Intraarticular (MOZ, Class III) · First FDA decision Nov 13, 2017, newest Nov 13, 2017Knee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Trivisc"
MAUDE reports
3
Brand "Trivisc", since 2015
PubMed studies
1
Mentioning "Trivisc"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TRIVISCPMA
P160057 · Decided Nov 13, 2017 · 325 days after receipt
Device type: Acid, hyaluronic, intraarticular (MOZ) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Trivisc", any status and sponsor, newest update first.
No registered device study names "Trivisc".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trivisc", and for the whole product code for context.
This brand
3 reports: 1 malfunction, 2 injury, 0 death
Whole product code MOZ
4,975 reports: 669 malfunction, 3,945 injury, 278 death
Newest reports for this brand
MW5150988 · Received Feb 1, 2024 · Event dated Sep 28, 2023
Device type: Acid, Hyaluronic, Intraarticular (MOZ)
Patient problem as coded: Muscle Weakness/Atrophy; Pain
- TRIVISCInjury
MW5113569 · Received Nov 30, 2022 · Event dated Oct 5, 2022
Device type: Acid, Hyaluronic, Intraarticular (MOZ)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Inflammation; Pain; Hyperresponsive to stimuli
- TRIVISCMalfunction
MW5110799 · Received Jul 11, 2022 · Event dated Jul 7, 2022 · 4 other devices named on this report
Device type: Acid, Hyaluronic, Intraarticular (MOZ)
Device problem as coded: Failure to Deliver; Detachment of Device or Device Component
Patient problem as coded: Foreign Body In Patient
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Trivisc"[tiab]. The summary above synthesizes these.
- Two new intra-articular injections for knee osteoarthritis.
Med Lett Drugs Ther · 2018
Other devices of this type
Also filed under product code MOZ.
- EUFLEXXA (1% Sodium Hyaluronate)Ferring Pharmaceuticals, Inc. · PMA 2017
- Gel-One(R)Seikagaku Corp. · PMA 2016
- Supartz FxSeikagaku Corp. · PMA 2016
- SupartzSeikagaku Corp. · PMA 2015
- Orthovisc High Molecular Weight HyaluronanAnika Therapeutics, Inc. · PMA 2011
- DurolaneBioventus, LLC · PMA 2020
- MonoviscAnika Therapeutics, Inc. · PMA 2020
- HyalganFidia Farmaceutici S.P.A. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.